Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

China stocks slip as healthcare shares, bond defaults weigh

11/17/2020 | 03:06am EDT

SHANGHAI, Nov 17 (Reuters) - China stocks ended lower on Tuesday, weighed by losses in healthcare stocks on concerns over lofty valuations, while more bond defaults hit sentiment.

** The blue-chip CSI300 index fell 0.2%, to 4,894.79, while the Shanghai Composite Index slipped 0.2% to 3,339.90 points.

** Falling the most, the CSI300 healthcare index slid 2.7%. Transport firms, in particular shipping and port firms, climbed as news of another promising coronavirus vaccine bolstered sentiment.

** Moderna Inc's experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.

** China's mutual funds shifted some of their positions to cyclical players for more safety margin as valuations of techs are too high now, said Yan Kaiwen, an analyst with China Fortune Securities.

** Yan added the recent bond defaults also hit market sentiment.

** Tsinghua Unigroup, a major government-backed player in China's technology race, has defaulted on a 1.3-billion-yuan ($197.96 million) bond, three sources said, as several high-profile delinquencies by state firms rattled the country's bond market.

** The default by Tsinghua Unigroup, a wholly-owned division of the prestigious Tsinghua University in Beijing, on Monday immediately triggered a credit rating downgrade that is expected to weaken the company's financial health.

** China should set an annual average economic growth target of around 5% for the 2021-2025 period, a senior economist at a Chinese state think tank said on Tuesday.

** Separately, a top Chinese securities regulator said on Tuesday that he hoped Sino-U.S. relations will improve under a Biden administration. (Reporting by Shanghai Newsroom; Editing by Ramakrishnan M.)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
MODERNA, INC. 4.06% 208.0659 Delayed Quote.90.67%
S&P/CITIC 300 INDEX -0.24% 4544.98 Delayed Quote.-0.81%
S&P/CITIC 50 INDEX -0.62% 4497.32 Delayed Quote.-2.97%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.11% 6.4632 Delayed Quote.-0.60%
All news about MODERNA, INC.
04:00pWall Street ends sharply higher, led by surging Dow
RE
03:30pMODERNA  : Canadians encouraged to see mRNA shots as interchangeable as more 2nd..
AQ
02:41pDow leads the way in broad Wall Street rally
RE
12:33pMODERNA  : White House to share millions of COVID-19 shots with Latam, Africa, A..
RE
12:04pMODERNA  : WHO setting up hub to make COVID-19 vaccines in South Africa
RE
12:04pMODERNA  : WHO setting up hub to make COVID-19 vaccines in South Africa
RE
12:00pMODERNA  : White House lays out plan to share remaining 55 mln U.S. COVID-19 sho..
RE
11:56aMODERNA  : Boosts COVID-19 Vaccine Production Capacity to Triple Output in 2022
MT
11:53aWall St bounces back on boost from banks, industrials
RE
11:49aWho chief scientist says talking to pfizer and moderna about their involvemen..
RE
More news
Financials (USD)
Sales 2021 18 664 M - -
Net income 2021 10 397 M - -
Net cash 2021 11 520 M - -
P/E ratio 2021 8,08x
Yield 2021 -
Capitalization 79 980 M 79 980 M -
EV / Sales 2021 3,67x
EV / Sales 2022 3,72x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 168,87 $
Last Close Price 199,19 $
Spread / Highest target 23,5%
Spread / Average Target -15,2%
Spread / Lowest Target -58,3%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.90.67%79 980
LONZA GROUP AG14.63%52 508
IQVIA HOLDINGS INC.33.76%45 934
CELLTRION, INC.-24.79%32 465
SEAGEN INC.-10.75%28 367
HANGZHOU TIGERMED CONSULTING CO., LTD14.49%24 102